tag asia 
PharmaShots
APRIL 14, 2023
Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)
European Pharmaceutical Review
DECEMBER 9, 2022
The research noted that the oligonucleotide synthesis market in the Asia-Pacific region is expected to develop at the quickest rate during the forecast period. Tag Copenhagen A/S (Denmark). This is because of their wide applications in polymerase chain reaction (PCR), sequencing, gene synthesis and cloning. CSBIO (US).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 5, 2022
Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In Asia, Africa and the Middle East, cannabinoid-based drugs are mostly illegal and continue to present a major regulatory obstacle.
Pharmaceutical Technology
JULY 8, 2022
The next most difficult place to fill these roles was found to be Asia-Pacific, while North America was in third place. On a regional level, these roles were hardest to fill in Europe, with related jobs that were taken offline in Q1 2022 having been online for an average of 35.1
pharmaphorum
JULY 23, 2019
This pharmaphorum webinar, in association with Tag, will examine the challenges that pharma marketing faces to stay ahead of the evolving customer journey and offer expert insight from both the pharma and FMCG sectors on how to convert these challenges into opportunities.
Pharmaceutical Technology
DECEMBER 15, 2022
The Cardiomyopathies: 68-Market Analysis and Sales Forecast report covers a total of 68 markets across Africa, Asia-Pacific (APAC), Europe, Latin America (LATAM), the Middle East and North America. The second highest contributing market is APAC, generating 33.2% of global cardiomyopathies sales in 2021 and 31.2%
pharmaphorum
NOVEMBER 27, 2022
For some products, this results in supply chains that are so complex that they start in Asia and circumnavigate the globe twice, before reaching the final destination. In recent years, the UK pharmaceutical industry has relied heavily on China and India as providers of active pharmaceutical ingredients.
Expert insights. Personalized for you.
40 
Let's personalize your content